Improving the management of non-ST elevation acute coronary syndromes:systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: the EQUIP-ACS project protocol and design

Flather, Marcus D., Booth, Jean, Babalis, Daphne, Bueno, Hector, Steg, Philippe G., Opolski, Grzegorz, Ottani, Filippo, Machecourt, Jacques, Bardaji, Alfredo, Bojestig, Mats, Brady, Anthony R. and Lindahl, Bertil (2010) Improving the management of non-ST elevation acute coronary syndromes:systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: the EQUIP-ACS project protocol and design. Trials, 11. ISSN 1745-6215

Full text not available from this repository. (Request a copy)

Abstract

Acute coronary syndromes, including myocardial infarction and unstable angina, are important causes of premature mortality, morbidity and hospital admissions. Acute coronary syndromes consume large amounts of health care resources, and have a major negative economic and social impact through days lost at work, support for disability, and coping with the psychological consequences of illness. Several registries have shown that evidence based treatments are under-utilised in this patient population, particularly in high-risk patients. There is evidence that systematic educational programmes can lead to improvement in the management of these patients. Since application of the results of important clinical trials and expert clinical guidelines into clinical practice leads to improved patient care and outcomes, we propose to test a quality improvement programme in a general group of hospitals in Europe.

Item Type:	Article
Uncontrolled Keywords:	acute coronary syndrome,adrenergic beta-antagonists,angiotensin-converting enzyme inhibitors,anticoagulants,coronary angiography,cost-benefit analysis,europe,feasibility studies,health care costs,health services research,humans,hydroxymethylglutaryl-coa reductase inhibitors,outcome and process assessment (health care),platelet aggregation inhibitors,program development,program evaluation,quality indicators, health care,research design,risk assessment,risk factors,time factors,treatment outcome,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023) Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health
Depositing User:	Pure Connector
Date Deposited:	20 Jan 2014 16:12
Last Modified:	24 Oct 2022 05:36
URI:	https://ueaeprints.uea.ac.uk/id/eprint/46254
DOI:	10.1186/1745-6215-11-5

Actions (login required)

View Item